|
End-of-day quote
Nasdaq
2026-08-25
|
5-day change | 1st Jan Change | ||
| 112.11 USD | +1.85% |
|
-2.97% | +172.05% |
| Market Cap | 6.27B 5.37B 5.04B 4.6B 8.68B 598B 8.77B 59.39B 23.12B 302B 23.55B 23.03B 999B | P/E 2026 * |
-29.1x | P/E 2027 * | -23.7x |
|---|---|---|---|---|---|
| Enterprise Value | 5.17B 4.43B 4.15B 3.79B 7.15B 493B 7.22B 48.94B 19.05B 249B 19.4B 18.98B 823B | EV / Sales 2026 * |
2,849x | EV / Sales 2027 * | 2,868x |
| Free-Float |
99.88% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Dianthus Therapeutics, Inc.
| 1 day | +1.85% | ||
| 1 week | -2.97% | ||
| Current month | +4.85% | ||
| 1 month | +7.93% | ||
| 3 months | +29.64% | ||
| 6 months | +116.14% | ||
| Current year | +172.05% |
| 1 week | 105.05 |  | 113.86 |
| 1 month | 100 | | 117.88 |
| Current year | 35.84 | | 117.88 |
| 1 year | 22.81 | | 117.88 |
| 3 years | 6.58 | | 117.88 |
| 5 years | 6.58 | | 117.88 |
| 10 years | 6.58 | | 117.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marino Garcia
CEO | Chief Executive Officer | 59 | 2023-09-10 |
Ryan Savitz
DFI | Director of Finance/CFO | 37 | 2023-09-10 |
Ronny Hashmonay
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 2023-09-10 | |
Jonathan Violin
BRD | Director/Board Member | 50 | 2023-09-10 |
Alison Lawton
CHM | Chairman | 63 | 2023-09-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/19/26 | Fiscal year | Director | 8,334 | 0.0149% | ||
| 8/13/26 | Fiscal year | General Counsel | 30,000 | 0.0536% | ||
| 8/10/26 | Fiscal year | Director | 23,250 | 0.0416% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.85% | -2.97% | +378.90% | - | 6.27B | |
| +3.31% | -3.70% | +61.03% | +103.64% | 71.35B | |
| +1.74% | +1.06% | +49.02% | +87.38% | 64.17B | |
| +1.09% | +22.96% | +8.55% | -3.03% | 28.65B | |
| -0.07% | -3.56% | -3.45% | +467.26% | 27.06B | |
| -3.26% | +5.53% | +54.97% | +11.71% | 27.33B | |
| +3.98% | +4.37% | +39.47% | -14.65% | 20.47B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 19.36B | |
| +0.10% | 0.00% | +7.80% | +542.33% | 15.96B | |
| +3.98% | +6.78% | +49.66% | +157.94% | 14.05B | |
| Average | +1.37% | +3.88% | +91.54% | +196.99% | 29.47B | |
| Weighted average by Cap. | +1.56% | +3.21% | +62.36% | +154.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.81M 1.55M 1.46M 1.33M 2.51M 173M 2.54M 17.18M 6.69M 87.24M 6.81M 6.66M 289M | 1.72M 1.47M 1.38M 1.26M 2.38M 164M 2.4M 16.25M 6.33M 82.55M 6.44M 6.3M 273M |
| Net income | -207M -177M -166M -152M -286M -19.71B -289M -1.96B -762M -9.94B -776M -759M -32.93B | -270M -232M -217M -198M -374M -25.78B -378M -2.56B -997M -13.01B -1.02B -993M -43.07B |
| Net Debt | -1.1B -946M -886M -809M -1.53B -105B -1.54B -10.45B -4.07B -53.07B -4.14B -4.05B -176B | -1.35B -1.16B -1.08B -989M -1.87B -129B -1.88B -12.77B -4.97B -64.85B -5.06B -4.95B -215B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | US$112.11 | +1.85% | 552,022 |
| 26-08-24 | US$110.07 | -0.93% | 531,928 |
| 26-08-21 | US$111.10 | +1.45% | 730,873 |
| 26-08-20 | US$109.51 | -3.69% | 735,475 |
| 26-08-19 | US$113.70 | -1.59% | 793,271 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNTH Stock
Select your edition
All financial news and data tailored to specific country editions
